Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure

Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure

Currently, the development of chronic heart failure (CHF) is considered from the perspective of pathological structural remodeling of myocardium and fibrosis. Despite the widespread use of molecular genetic markers in clinical practice, only a small number of them are used to evaluate remodeling pro...

Full description

Bibliographic Details
Main Authors:	T. B. Pecherina, A. G. Kutikhin
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2020-11-01
Series:	Российский кардиологический журнал
Subjects:	heart failure myocardial fibrosis biomarkers genetic regulation
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3933

Similar Items

Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients
by: Yiling Yao, et al.
Published: (2021-05-01)

The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation—The HARVEST-Malmö study
by: Zainu Nezami, et al.
Published: (2022-10-01)

MOLECULAR BIOMARKERS FOR DIAGNOSTICS, RISK STRATIFICATION AND PREDICTION OF CHRONIC HEART FAILURE
by: E. A. Medvedeva, et al.
Published: (2016-08-01)

Identification of diagnostic model in heart failure with myocardial fibrosis and conduction block by integrated gene co-expression network analysis
by: Yonghua Yuan, et al.
Published: (2024-02-01)

Markers of fibrosis in ischemic chronic heart failure and renal dysfunction
by: V. D. Syvolap, et al.
Published: (2015-06-01)

Profile of serum microRNAs in heart failure with reduced and preserved ejection fraction: Correlation with myocardial remodeling
by: Layde Rosane Paim, et al.
Published: (2024-03-01)

Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review
by: Asparuh Nikolov, et al.
Published: (2022-03-01)

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01)

Detection of myocardial fibrosis: Where we stand
by: Leyi Zhu, et al.
Published: (2022-09-01)

Biomarkers of Myocardial Injury and Remodeling in Heart Failure
by: Barbara Ponikowska, et al.
Published: (2022-05-01)

Analyses of factors influencing myocardial fibrosis in non-ischemic heart failure patients
by: WANG Fang, DONG Zhe, SUN Yi-hong, REN Jing-yi, LI Jing, ZHOU Yi-feng, ZHENG Jin-gang
Published: (2021-03-01)

Myocardial fibrosis in congenital heart disease
by: Blanca Gordon, et al.
Published: (2022-11-01)

Interleukin-6 and adhesion molecules VCAM-1 and ICAM-1 as biomarkers of post-acute myocardial infarction heart failure
by: D.O.C. Lino, et al.
Published: (2019-11-01)

Biomarkers in patients with myocardial fibrosis
by: An Zhe, et al.
Published: (2017-10-01)

Novel Biomarkers of Heart Failure in Pediatrics
by: Teja Senekovič Kojc, et al.
Published: (2022-05-01)

Correlation between serum matrix metalloproteinase and myocardial fibrosis in heart failure patients with reduced ejection fraction: A retrospective analysis
by: Ömer Çelik, et al.
Published: (2020-10-01)

Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction
by: Stuart B. Prenner, et al.
Published: (2020-02-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
by: Franziska E. Uhl, et al.
Published: (2022-07-01)

Heart Failure, Left Ventricular Remodeling, and Circulating Nitric Oxide Metabolites
by: Julio A. Chirinos, et al.
Published: (2016-10-01)

Extracellular matrix remodeling in patients with ischemic chronic heart failure with preserved ejection fraction
by: V. D. Syvolap, et al.
Published: (2015-04-01)

Novel Biomarkers in Heart Failure: New Insight in Pathophysiology and Clinical Perspective
by: Luigi Marzio Biasucci, et al.
Published: (2021-06-01)

Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction
by: Giovanni Battista Bolla, et al.
Published: (2022-05-01)

Myocardial fibrosis: Current aspects of the problem
by: V N Karetnikova, et al.
Published: (2017-01-01)

Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans
by: Liang-Yu Lin, et al.
Published: (2018-11-01)

Alamandine alleviated heart failure and fibrosis in myocardial infarction mice
by: Kun Zhao, et al.
Published: (2022-09-01)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
by: Fuyu Zhu, et al.
Published: (2022-09-01)

Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)

Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure
by: Zeyu Zhang, et al.
Published: (2024-04-01)

EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Role of the cardiac extracellular matrix in the onset and progression of heart failure
by: N. N. Ilov, et al.
Published: (2021-07-01)

Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure
by: Tong Liu, et al.
Published: (2017-04-01)

Biomarkers of Systemic Versus Local Inflammation During the Acute Phase of Myocardial Infarction, as Predictors of Post-infarction Heart Failure
by: Matyas Botond, et al.
Published: (2021-09-01)

Prognostic value of the liver fibrosis marker fibrosis‐5 index in patients with acute heart failure
by: Daichi Maeda, et al.
Published: (2022-04-01)

EFFICIENCY OF ENDOVASCULAR MYOCARDIAL REVASCULARIZATION AS A «BRIDGE» TO HEART TRANSPLANTATION IN PATIENTS WITH ISCHEMIC HEART FAILURE
by: A. B. Mironkov, et al.
Published: (2017-01-01)

Single cell and lineage tracing studies reveal the impact of CD34+ cells on myocardial fibrosis during heart failure
by: Luping Du, et al.
Published: (2023-02-01)

RUNX1 facilitates heart failure progression through regulating TGF-β-induced cardiac remodeling
by: Peng Qi, et al.
Published: (2023-10-01)

Association of plasma biomarkers and interstitial myocardial fibrosis in fontan population: A machine learning approach
by: Vien T. Truong, et al.
Published: (2022-03-01)

Pathogenetic treatment of chronic heart failure: the role of torasemide
by: N B Perepech
Published: (2015-09-01)

Serum microRNAs are key predictors of long‐term heart failure and cardiovascular death after myocardial infarction
by: Luis M. Rincón, et al.
Published: (2022-10-01)